156 related articles for article (PubMed ID: 12579978)
21. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
22. Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives.
Martínez-Sancho C; Herrero-Vanrell R; Negro S
J Microencapsul; 2003; 20(6):799-810. PubMed ID: 14594668
[TBL] [Abstract][Full Text] [Related]
23. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
Pagar KP; Vavia PR
Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
[TBL] [Abstract][Full Text] [Related]
24. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices.
Hickey T; Kreutzer D; Burgess DJ; Moussy F
J Biomed Mater Res; 2002 Aug; 61(2):180-7. PubMed ID: 12007197
[TBL] [Abstract][Full Text] [Related]
25. Effects of dexamethasone-loaded PLGA microspheres on human fetal osteoblasts.
Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; van Leeuwen JP; Duszczyk J; Eijken M
J Biomater Appl; 2012 Nov; 27(4):477-83. PubMed ID: 21862514
[TBL] [Abstract][Full Text] [Related]
26. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers.
Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
Int J Pharm; 2006 Dec; 326(1-2):139-47. PubMed ID: 16971074
[TBL] [Abstract][Full Text] [Related]
27. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.
Giordano GG; Refojo MF; Arroyo MH
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796
[TBL] [Abstract][Full Text] [Related]
28. Rifampicin carrying poly (D,L-lactide)/poly(ethylene glycol) microspheres: loading and release.
Celikkaya E; Denkbaş EB; Pişkin E
Artif Organs; 1996 Jul; 20(7):743-51. PubMed ID: 8828763
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.
Xu X; Zhao C; Yang H; Jian Y; Zhang Z; Huang Y
Drug Deliv; 2011; 18(7):485-92. PubMed ID: 21692681
[TBL] [Abstract][Full Text] [Related]
30. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
[TBL] [Abstract][Full Text] [Related]
31. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.
Fialho SL; Behar-Cohen F; Silva-Cunha A
Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057
[TBL] [Abstract][Full Text] [Related]
32. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
33. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.
Moon SW; Sun Y; Warther D; Huffman K; Freeman WR; Sailor MJ; Cheng L
Drug Deliv; 2018 Jan; 25(1):600-610. PubMed ID: 29461171
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
36. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
37. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
[TBL] [Abstract][Full Text] [Related]
38. Sustained local drug delivery to the arterial wall via biodegradable microspheres.
Dev V; Eigler N; Fishbein MC; Tian Y; Hickey A; Rechavia E; Forrester JS; Litvack F
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):324-32. PubMed ID: 9213032
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy.
Kuo HK; Chen YH; Wu PC; Kuo YH
Ophthalmologica; 2015; 233(3-4):198-203. PubMed ID: 25721986
[TBL] [Abstract][Full Text] [Related]
40. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
Pollauf EJ; Kim KK; Pack DW
J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
